Stock Report

All about this stock under one free report Last Updated: 10-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Nektar Therapeutics (NKTR) Key Ratios

Stock Card factsheet share-fund-plan-icon

$73.32

up-down-arrow $-2.12 (-2.81%)

As on 09-Sep-2026 16:00EDT

Market cap

info icon

$2,533 Mln

Revenue (TTM)

info icon

$55 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -6.72 -9.34 -27.15 -14.63 -12.34
EBIT -- -- -3.83 18.54 12.28
Net Profit 9.54 2.33 -28.51 17.95 10.78
EPS 32.30 58.38 15.76 19.33 12.64
Book Value -- -- 3.76 -46.69 -45.25
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -206.96-290.60-169.79-249.91-92.54
Net Margin info ---727.12-287.84----
Return on equity info -151.00-116.60-31.65-217.94-124.10
Return on Capital info -71.09-64.03---81.62-57.74
Return on Assets info -46.62-43.92-21.75-56.17-33.90
Debt to Equity (x) info ----0.001.661.69

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
-81.62
-57.74
-73.92
-55.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-31.65

Lower than Peers by 50.62

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-31.65
-217.94
-124.10
-110.95
-70.39
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-21.75

Lower than Peers by 24.60

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-21.75
-56.17
-33.90
-49.80
-40.29
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-169.79

Lower than Peers by 185.61

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-169.79
-249.91
-92.54
-278.42
-365.08
Peer Median
15.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-287.84

Lower than Peers by 296.07

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-287.84
-297.07
-120.86
-306.31
-399.98
Peer Median
8.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-27.15

Lower than Peers by 35.20

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-27.15
-0.44
0.09
-0.02
-0.10
Peer Median
8.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-3.83

Lower than Peers by 12.09

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-3.83
-51.53
63.70
25.34
29.39
Peer Median
8.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-28.51

Lower than Peers by 36.24

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-28.51
-37.92
56.91
25.03
29.71
Peer Median
7.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

15.76

Higher than Peers by 5.37

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
15.76
0.03
0.61
0.26
0.31
Peer Median
10.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

1,689.74

Higher than Peers by 1,684.86

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
1,689.74
--
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
1.66
1.69
0.90
0.36
Peer Median
0.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
0.03
0.23
0.33
0.15
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

10.42

Higher than Peers by 8.77

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
10.42
4.97
4.26
6.45
8.00
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

10.42

Higher than Peers by 9.22

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
10.42
--
4.26
6.14
7.72
Peer Median
1.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-4.06

Lower than Peers by 8.83

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-4.06
-5.27
-3.24
-9.90
-11.62
Peer Median
4.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

8.71

Lower than Peers by 12.56

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
8.71
3.22
1.63
2.50
9.13
Peer Median
21.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.08

Lower than Peers by 0.32

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
0.08
0.19
0.28
0.16
0.10
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
11.20
7.16
21.59
61.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
--
95.82
175.94
295.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
--
127.41
113.77
191.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
--
-24.42
83.77
164.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
-5.23
-0.11
-0.03
-0.08
Peer Median
37.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.75

Lower than Peers by 4.94

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
2.75
9.55
0.22
0.05
0.08
Peer Median
7.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
--
--
--
--
--
Peer Median
0.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-6.50

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
-6.50
-5.56
1.61
0.74
1.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

2,533

Lower than Peers by 36

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nektar Therapeutics (NKTR)
2,533
--
--
--
--
Peer Median
2,569
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...